Article
Minimal residual disease in acute myeloid leukemia: coming of age.
Hematology. American Society of Hematology. Education Program - 1 Jan 2012
Paietta Elisabeth
Abstract excerpt
The achievement of complete hematologic remission (CR) is a prerequisite for cure in acute myeloid leukemia (AML). The conventional definition of CR, based on the morphologic recognition of ≤ 5% of leukemic blasts in the BM, does not provide sufficient insight into the quality of the response. Despite CR rates of 50%-80% (depending on age), the majority of patients with AML relapse within 3-5 years from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.